ALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early-stage triple-negative breast cancer.

Heather L. McArthur, Michail Ignatiadis, Sebastian Guillaume, Andrew Bailey, Jorge Luis Martinez, Mariana Brandao, Otto Metzger, Catherine Lai, Debora Fumagalli, Fergus Daly, Aicha Bouhlel, Valeria Karusinova, Christie Freeman, Giuseppe Viale, Vanessa Honvault, Carter Dufrane, Anh Nguyen Duc, Martine J. Piccart, Eric S. Winer, Richard D. Gelber

Research output: Contribution to journalAbstractpeer-review

Original languageEnglish
Number of pages2
JournalJournal of Clinical Oncology
Issue number15
Publication statusPublished - 20 May 2019
EventAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, Israel
Duration: 31 May 20194 Jun 2019

Cite this